Summary & Overview
HCPCS Q4353: Xceed tl Matrix, Wound Management Add-On
Headline: HCPCS Level II code Q4353 clarifies add-on billing for Xceed tl matrix
Lead: HCPCS Level II code Q4353 designates the Xceed tl matrix, billed per square centimeter as an add-on to a primary procedure. The code standardizes reporting for a medical device used in wound management and reconstructive procedures, affecting facility and procedure-level billing across multiple payers.
What the code represents and why it matters: The code identifies a discrete, measurable application of a biologic/synthetic matrix product in conjunction with primary surgical care. Accurate use of Q4353 matters nationally because it affects procedure cost accounting, device utilization tracking, and payer coverage determinations for adjunctive wound-care products.
Key payers covered: Analysis includes major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication provides benchmarks for add-on device billing, summarizes payer coverage patterns, and outlines clinical contexts in which the matrix is applied. Readers will find operational details on coding placement (add-on, per square centimeter reporting), implications for site-of-service billing, and areas where policy updates or payer edits commonly affect reimbursement. Data not available in the input where specific utilization metrics, taxonomies, ICD-10 mappings, and related codes would normally appear.
Billing Code Overview
HCPCS Level II code Q4353 describes the Xceed tl matrix, billed per square centimeter as an add-on and reported in addition to a primary procedure. The service represents use of a specialized wound management matrix product applied in conjunction with a primary surgical or wound-care procedure.
-
Service type: Medical device product used in wound management or reconstructive procedures
-
Typical site of service: Hospital outpatient departments, ambulatory surgical centers, and other procedural settings where a primary wound or reconstructive procedure is performed
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or deep partial-thickness skin loss from trauma, surgical excision of nonhealing wounds, or chronic ulceration who requires application of a biologic dermal matrix graft. The procedure using Q4353 (Xceed TL Matrix per square centimeter, add-on) is provided in an outpatient wound care clinic or hospital outpatient department or in the operating room for larger or complex wounds. The clinical workflow begins with wound assessment (size, depth, infection status), debridement of devitalized tissue, hemostasis, and irrigation. The provider sizes the defect, prepares the wound bed, and applies the Xceed TL Matrix trimmed to fit; the product is documented by square centimeters and billed as an add-on code in addition to the primary surgical or grafting procedure. Post-application dressing, immobilization (if applicable), and scheduled follow-up for graft take and dressing changes complete the encounter. Typical payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/standard service | Use when no specific modifier applies and the service is billed as submitted. |